Dessalegn Mekonnen Birye
Department of Nursing, Teda Health Science College, P.O. BOX 790, Gondar, Ethiopia.
Adv Prev Med. 2021 May 28;2021:6615008. doi: 10.1155/2021/6615008. eCollection 2021.
Hepatitis C virus infection during pregnancy is associated with a high risk of maternal complications and poor birth outcomes. There are variable reports on the prevalence of hepatitis C virus infection among pregnant women in Ethiopia. Therefore, this study aims to estimate the pooled prevalence of hepatitis C virus infection among pregnant women in Ethiopia.
A comprehensive search of electronic databases including PubMed, Scopus, EMBASE, the Cochrane Library, Web of Sciences, and Google Scholar was conducted from April 03, 2020, to May 03, 2020. The quality of included article was evaluated by the JBI. Heterogeneity between the studies was assessed using Cochrane and test. The presence of publication bias was tested by funnel plots and Egger's test. A random-effects meta-analysis was computed to determine the pooled prevalence of HCV infection among pregnant women.
Of 502 studies, 6 studies with a total of 2117 pregnant women were included in the meta-analysis. The overall pooled prevalence of hepatitis virus infection among pregnant women in Ethiopia was 1.83% (95% CI: 0.61, 3.06). Besides, subgroup analysis revealed that the highest HCV prevalence among pregnant women was observed in Oromia region, 5.10% (95% CI: -0.53, 10.73).
This study shows an intermediate level of HCV infection among pregnant women in Ethiopia. The finding suggests the need of implementing a routine hepatitis virus screening program for all pregnant women, which enables women to access HCV antiviral treatment to minimize vertical transmission to the newborn infants. Moreover, national and regional health programs should mandate and monitor the screening procedures so as to reduce the risk of hepatitis virus infection.
孕期丙型肝炎病毒感染与孕产妇并发症风险高及不良分娩结局相关。关于埃塞俄比亚孕妇中丙型肝炎病毒感染率的报道不一。因此,本研究旨在估计埃塞俄比亚孕妇中丙型肝炎病毒感染的合并患病率。
于2020年4月3日至2020年5月3日对包括PubMed、Scopus、EMBASE、Cochrane图书馆、科学网和谷歌学术在内的电子数据库进行全面检索。纳入文章的质量由JBI评估。使用Cochrane 和 检验评估研究间的异质性。通过漏斗图和Egger检验检测发表偏倚的存在。计算随机效应荟萃分析以确定孕妇中HCV感染的合并患病率。
在502项研究中,有6项研究共2117名孕妇被纳入荟萃分析。埃塞俄比亚孕妇中丙型肝炎病毒感染的总体合并患病率为1.83%(95%CI:0.61,3.06)。此外,亚组分析显示,奥罗米亚地区孕妇的HCV患病率最高,为5.10%(9